GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Prednisone

Company
National Human Genome Research Institute (NHGRI)
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
62 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

62 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for Prednisone and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT00501826

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

    Not yet reported M.D. Anderson Cancer Center 160 participants Est. completion 2026-10-31 1 site Stand-alone
    Other conditions: T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
    View official trial listing →
  • Recruiting NCT NCT02784210

    Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 30 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Recruiting NCT NCT03223610

    Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

    Not yet reported, Not yet reported National Cancer Institute (NCI) 155 participants Est. completion 2027-12-01 1 site Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Burkitt Lymphoma
    View official trial listing →
  • Recruiting NCT NCT03760835

    Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment

    Not yet reported Federico II University 150 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Congenital Adrenal Hyperplasia
    View official trial listing →
  • Recruiting NCT NCT03952637

    A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis

    Not yet reported, Not yet reported National Human Genome Research Institute (NHGRI) 54 participants Est. completion 2030-01-01 1 site Stand-alone
    Other conditions: Lysosomal Diseases, Gangliosidosis, GM1
    View official trial listing →
  • Recruiting NCT NCT04182984

    TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study

    Tang-Du Hospital 200 participants Est. completion 2026-06-30 1 site
    Other conditions: Ocular Myasthenia Gravis
    View official trial listing →
  • Recruiting NCT NCT04301076

    Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

    Not yet reported National Cancer Institute (NCI) 30 participants Est. completion 2027-06-30 19 sites Stand-alone
    Other conditions: Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma, HTLV-1 Infection
    View official trial listing →
  • Recruiting NCT NCT04442412

    Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy

    Not yet reported Fondazione Italiana Linfomi - ETS 430 participants Est. completion 2030-09-01 49 sites Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma, Elderly Patients
    View official trial listing →
  • Recruiting NCT NCT04469842

    Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

    Not yet reported Vanderbilt University Medical Center 48 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Lung Transplant; Complications
    View official trial listing →
  • Recruiting NCT NCT04633252

    A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 86 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Cancer Of Prostate, Prostate Neoplasms
    View official trial listing →
  • Recruiting NCT NCT04702256

    Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF

    Not yet reported Assistance Publique - Hôpitaux de Paris 196 participants Est. completion 2031-12 1 site Stand-alone
    Other conditions: Lupus Nephritis, Systemic Lupus Erythematosus (SLE)
    View official trial listing →
  • Recruiting NCT NCT04734730

    Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer

    Not yet reported City of Hope Medical Center 70 participants Est. completion 2027-08-23 1 site Stand-alone
    Other conditions: Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT04875702

    Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

    Not yet reported Massachusetts General Hospital 650 participants Est. completion 2028-10-31 7 sites
    Other conditions: Gout
    View official trial listing →
  • Recruiting NCT NCT04918524

    The Clinical Features and Pregnancy Outcomes of CTD Patients

    Qilu Hospital of Shandong University 126 participants Est. completion 2026-12-31 1 site
    Other conditions: Connective Tissue Diseases, Pregnancy Related
    View official trial listing →
  • Recruiting NCT NCT05102448

    Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

    Not yet reported Shanghai Zhongshan Hospital 76 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Takayasu Arteritis
    View official trial listing →
  • Recruiting NCT NCT05176483

    Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    Not yet reported Exelixis 1394 participants Est. completion 2030-06-28 122 sites Stand-alone
    Other conditions: Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor, Hepatocellular Carcinoma (HCC), Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC), Clear Cell Renal Cell Carcinoma (ccRCC), Non-Clear Cell Renal Cell Carcinoma (nccRCC), Drug-Drug Interaction (DDI)
    View official trial listing →
  • Recruiting NCT NCT05201469

    VIBRANT: VIB4920 for Active Lupus Nephritis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 74 participants Est. completion 2027-03 17 sites Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Recruiting NCT NCT05327894

    Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

    Not yet reported Princess Maxima Center for Pediatric Oncology 160 participants Est. completion 2030-09 124 sites
    Other conditions: Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia
    View official trial listing →
  • Recruiting NCT NCT05489211

    Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

    Not yet reported AstraZeneca 454 participants Est. completion 2027-10-01 96 sites Stand-alone
    Other conditions: Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Urothelial Cancer, Biliary Tract Cancer
    View official trial listing →
  • Recruiting NCT NCT05600686

    Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma

    Not yet reported University of California, Davis 24 participants Est. completion 2027-12-15 2 sites Stand-alone
    Other conditions: Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
    View official trial listing →
  • Recruiting NCT NCT05681260

    Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)

    Not yet reported Children's Cancer Group, China 200 participants Est. completion 2029-12-31 2 sites Stand-alone
    Other conditions: T-cell Lymphoblastic Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05958719

    Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 37 participants Est. completion 2027-03-02 1 site Stand-alone
    Other conditions: Peripheral T Cell Lymphoma, Epigenetic Repression
    View official trial listing →
  • Recruiting NCT NCT06037811

    Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

    Not yet reported Tom Appleton 30 participants Est. completion 2028-12 1 site
    Other conditions: Inflammatory Arthritis, Immune-related Adverse Event
    View official trial listing →
  • Recruiting NCT NCT06220487

    A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL

    Not yet reported Nanfang Hospital, Southern Medical University 67 participants Est. completion 2028-01-01 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Philadelphia Chromosome, Philadelphia-Positive ALL, Adult ALL, IKZF1 Gene Mutation
    View official trial listing →
  • Recruiting NCT NCT06280950

    Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 340 participants Est. completion 2030-06-30 8 sites Stand-alone
    Other conditions: Liver Transplant
    View official trial listing →
  • Recruiting NCT NCT06284122

    Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5

    Not yet reported The Lymphoma Academic Research Organisation 790 participants Est. completion 2034-04 116 sites
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06474273

    A Multicenter Randomized Controlled Trial to Treat Acute T Cell Mediated Rejection in Kidney and Kidney-Pancreas Transplant Recipients

    Not yet reported University of Sydney 540 participants Est. completion 2030-06 30 sites Stand-alone
    Other conditions: Rejection; Transplant, Kidney, Rejection; Transplant, Pancreas
    View official trial listing →
  • Recruiting NCT NCT06564038

    A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

    Not yet reported, Not yet reported AstraZeneca 408 participants Est. completion 2029-06-11 65 sites Stand-alone
    Other conditions: Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma, B-cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06568094

    A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer

    Not yet reported, Not yet reported Jiangsu HengRui Medicine Co., Ltd. 100 participants Est. completion 2027-06 2 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT06594640

    R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

    Not yet reported, Not yet reported Institute of Hematology & Blood Diseases Hospital, China 108 participants Est. completion 2027-07-30 1 site Stand-alone
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06630130

    Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer

    Not yet reported Jeeyun Lee 100 participants Est. completion 2029-06-30 1 site
    Other conditions: Stomach Neoplasms
    View official trial listing →
  • Recruiting NCT NCT06649812

    Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 120 participants Est. completion 2028-09-01 96 sites Stand-alone
    Other conditions: High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements, Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified, Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements, Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified, Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06689163

    A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone

    Not yet reported, Not yet reported Jiangsu HengRui Medicine Co., Ltd. 66 participants Est. completion 2026-12-31 2 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT06701357

    CR-CHOP+X in Previously Untreated DEL

    Not yet reported Ruijin Hospital 49 participants Est. completion 2028-12-01 1 site Stand-alone
    Other conditions: DLBCL
    View official trial listing →
  • Recruiting NCT NCT06738368

    Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia

    Not yet reported University of Washington 30 participants Est. completion 2028-07-30 1 site Stand-alone
    Other conditions: B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, T Acute Lymphoblastic Leukemia
    View official trial listing →
  • Recruiting NCT NCT06743945

    POLA-R-CHP in the First-line Treatment of Transformed DLBCL

    Not yet reported Fudan University 20 participants Est. completion 2029-12 1 site Stand-alone
    Other conditions: Transformed Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06780462

    Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone in Deep Venous Thrombosis of Behçet's Syndrome

    Not yet reported Assistance Publique - Hôpitaux de Paris 134 participants Est. completion 2028-06-24 17 sites Stand-alone
    Other conditions: Behcet Syndrome
    View official trial listing →
  • Recruiting NCT NCT06803693

    Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL

    Not yet reported Ruijin Hospital 152 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06887517

    Chinese Rheumatism Biobank(CRB)

    Chinese SLE Treatment And Research Group 300 participants Est. completion 2033-04-01 1 site
    Other conditions: Lupus Erythematosus, Systemic
    View official trial listing →
  • Recruiting NCT NCT06925737

    A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    Not yet reported Merck Sharp & Dohme LLC 1440 participants Est. completion 2031-01-06 296 sites
    Other conditions: Prostate Cancer, Prostatic Neoplasms
    View official trial listing →
  • Recruiting NCT NCT06970080

    Therapeutic Relevance of Abnormal Airway Morphology in Asthma

    Not yet reported McMaster University 242 participants Est. completion 2028-06 2 sites Stand-alone
    Other conditions: Asthma
    View official trial listing →
  • Recruiting NCT NCT06983821

    Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)

    Not yet reported Ottawa Hospital Research Institute 36 participants Est. completion 2029-02 2 sites Stand-alone
    Other conditions: Granulomatosis With Polyangiitis, Microscopic Polyangiitis (MPA)
    View official trial listing →
  • Recruiting NCT NCT07005154

    A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

    Not yet reported Astellas Pharma Global Development, Inc. 218 participants Est. completion 2032-05-31 54 sites Stand-alone
    Other conditions: Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT07053462

    CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

    Not yet reported, Not yet reported AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90 participants Est. completion 2028-12-28 1 site Stand-alone
    Other conditions: End-Stage Renal Disease, End Stage Renal Disease on Dialysis, End Stage Renal Disease With Renal Transplant, Kidney Transplant Rejection, Kidney Tumor, Kidney Failure, Kidney Ischemia
    View official trial listing →
  • Recruiting NCT NCT07058103

    Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of R/R AITL

    Not yet reported The Affiliated Hospital of Xuzhou Medical University 40 participants Est. completion 2028-04-01 1 site Stand-alone
    Other conditions: Angioimmunoblastic T-Cell Lymphoma Recurrent, Angioimmunoblastic T-Cell Lymphoma Refractory
    View official trial listing →
  • Recruiting NCT NCT07059156

    Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL

    Not yet reported, Not yet reported Shanxi Bethune Hospital 50 participants Est. completion 2027-07 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Adult
    View official trial listing →
  • Recruiting NCT NCT07133997

    Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia

    Not yet reported City of Hope Medical Center 26 participants Est. completion 2028-06-01 1 site Stand-alone
    Other conditions: Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia
    View official trial listing →
  • Recruiting NCT NCT07207954

    Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis

    Not yet reported Lifordi Immunotherapeutics, Inc. 176 participants Est. completion 2027-07-16 7 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT07225946

    A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

    Not yet reported Janssen Research & Development, LLC 800 participants Est. completion 2029-07-20 152 sites
    Other conditions: Prostatic Neoplasms, Castration-Resistant
    View official trial listing →
  • Recruiting NCT NCT07237269

    Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer

    Not yet reported University of Nebraska 140 participants Est. completion 2033-04-03 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT07242092

    Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs

    Not yet reported University of Sao Paulo General Hospital 192 participants Est. completion 2028-12-30 1 site Stand-alone
    Other conditions: Autoimmune Rheumatic Diseases
    View official trial listing →
  • Recruiting NCT NCT07286214

    Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica

    Not yet reported Sanofi 300 participants Est. completion 2029-07-16 14 sites Stand-alone
    Other conditions: Polymyalgia Rheumatica
    View official trial listing →
  • Recruiting NCT NCT07311694

    A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 370 participants Est. completion 2028-12 1 site
    Other conditions: PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT07365995

    A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

    Not yet reported BioNTech SE 736 participants Est. completion 2031-02 30 sites
    Other conditions: Metastatic Castration-resistant Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT07412470

    A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

    Not yet reported, Not yet reported Sanofi 526 participants Est. completion 2033-08-15 26 sites Stand-alone
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Recruiting NCT NCT07431060

    Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis

    Not yet reported West China Second University Hospital 120 participants Est. completion 2030-12-31 11 sites Stand-alone
    Other conditions: Langerhans Cell Histiocytosis (LCH)
    View official trial listing →
  • Recruiting NCT NCT07453368

    Orelabrutinib in the Treatment of Relapsed/Refractory AIHA

    Not yet reported Peking Union Medical College Hospital 50 participants Est. completion 2028-03-01 1 site Stand-alone
    Other conditions: Autoimmune Hemolytic Anemia (AIHA)
    View official trial listing →
  • Recruiting NCT NCT07493148

    Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL

    Not yet reported Ou Bai, MD/PHD 50 participants Est. completion 2029-12-30 1 site Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma (DLBCL)
    View official trial listing →
  • Recruiting NCT NCT07496229

    Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3)

    Not yet reported, Not yet reported Dizal Pharmaceuticals 165 participants Est. completion 2029-12 12 sites Stand-alone
    Other conditions: T-cell Lymphomas
    View official trial listing →
  • Recruiting NCT NCT07503379

    Evaluation of the Efficacy and Safety of Darolutamide + ADT Combined With Low-dose Docetaxel in mHSPC

    Not yet reported Yonghong Li 109 participants Est. completion 2028-12 3 sites
    Other conditions: mHSPC
    View official trial listing →
  • Recruiting NCT NCT07608978

    Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma of the MCD/BN2/N1 Subtypes

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 35 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma (DLBCL)
    View official trial listing →
  • Recruiting NCT NCT07730515

    Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma

    Not yet reported, Not yet reported Evopoint Biosciences Inc. 176 participants Est. completion 2028-09-30 1 site
    Other conditions: Non-hodgkin Lymphoma, Peripheral T-cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00000146

    Optic Neuritis Treatment Trial (ONTT)

    Not yet reported National Eye Institute (NEI) 15 sites
    Other conditions: Multiple Sclerosis, Optic Neuritis
    View official trial listing →
  • Completed NCT NCT00000524

    Myocarditis Treatment Trial

    Not yet reported University of Utah Est. completion 1994-03
    Cardiovascular disease Other conditions: Heart Diseases, Myocarditis
    View official trial listing →
  • Completed NCT NCT00000596

    Diffuse Fibrotic Lung Disease

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1983-01
    Other conditions: Lung Diseases, Pulmonary Fibrosis, Sarcoidosis
    View official trial listing →
  • Completed NCT NCT00002494

    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

    Not yet reported Alliance for Clinical Trials in Oncology 134 participants Est. completion 2006-01 23 sites Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00002499

    Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia

    Not yet reported, Not yet reported Grupo Argentino de Tratamiento de la Leucemia Aguda 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT00002599

    Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma

    Not yet reported Medical Research Council 750 participants 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00002766

    Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma

    Not yet reported Memorial Sloan Kettering Cancer Center 170 participants Est. completion 2011-09 7 sites Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00003490

    Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma

    Not yet reported The Cleveland Clinic 30 participants Est. completion 2003-08 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00003541

    Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 24 participants Est. completion 2006-07 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00003554

    Rituximab in Treating Patients With Multiple Myeloma

    Not yet reported The Cleveland Clinic Est. completion 2004-04 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00004162

    Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma

    Not yet reported University of Alabama at Birmingham 48 participants Est. completion 2001-01 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00004179

    Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 475 participants Est. completion 2017-07-19 261 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00004228

    Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma

    Not yet reported Children's Oncology Group 393 participants Est. completion 2015-03-31 176 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00005780

    Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 26 participants Est. completion 2021-06-16 1 site Stand-alone
    Other conditions: Mantle Cell Lymphoma, Lymphoma, Mantle Cell
    View official trial listing →
  • Completed NCT NCT00006436

    EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

    Not yet reported National Cancer Institute (NCI) 68 participants Est. completion 2024-01-18 1 site
    Other conditions: Lymphoma, AIDS-related, Lymphoma, Large B-Cell, Diffuse
    View official trial listing →
  • Completed NCT NCT00020943

    Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma

    Not yet reported Alliance for Clinical Trials in Oncology 79 participants Est. completion 2009-09 81 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00023244

    Steroid Withdrawal in Pediatric Kidney Transplant Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 274 participants Est. completion 2005-06 19 sites Stand-alone
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00051311

    Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers

    Not yet reported National Cancer Institute (NCI) 62 participants Est. completion 2014-09-25 1 site Stand-alone
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Completed NCT NCT00053768

    Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

    Not yet reported German High-Grade Non-Hodgkin's Lymphoma Study Group 392 participants Est. completion 2006-12-05 175 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00064116

    Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma

    Not yet reported NCIC Clinical Trials Group 824 participants Est. completion 2014-01-16 25 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00066469

    Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation

    Not yet reported Children's Oncology Group 55 participants Est. completion 2013-12-31 78 sites Stand-alone
    Other conditions: Lymphoproliferative Disorder
    View official trial listing →
  • Completed NCT NCT00069745

    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen

    Not yet reported Agennix Est. completion 2007-03 211 sites
    Other conditions: Prostate Cancer, Hormone Refractory Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00070083

    Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

    Not yet reported British Columbia Cancer Agency 4 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00072644

    Pharmacokinetic Interactions With Prednisolone in Healthy Volunteers and HIV-infected Patients Receiving Single-Dose Prednisone

    National Institutes of Health Clinical Center (CC) 75 participants Est. completion 2008-06-17 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00088530

    BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)

    Not yet reported CTI BioPharma 140 participants Est. completion 2010-07 99 sites Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Terminated NCT NCT00089856

    GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer

    Not yet reported Cell Genesys 626 participants Est. completion 2008-10 126 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT00092222

    Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

    Not yet reported National Cancer Institute (NCI) 75 participants Est. completion 2026-10-01 1 site
    Other conditions: Lymphoproliferative Disorder, HHV-8, Malignancy, HIV
    View official trial listing →
  • Completed NCT NCT00101010

    Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma

    Not yet reported M.D. Anderson Cancer Center 80 participants Est. completion 2014-09 7 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00117598

    Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

    Not yet reported Pfizer 169 participants Est. completion 2011-01 73 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00132691

    Multicenter Uveitis Steroid Treatment (MUST) Trial

    Not yet reported JHSPH Center for Clinical Trials 255 participants Est. completion 2010-12 23 sites
    Other conditions: Uveitis
    View official trial listing →
  • Terminated NCT NCT00133224

    Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

    Not yet reported Cell Genesys 408 participants Est. completion 2009-06 115 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00133991

    Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23 participants Est. completion 2013-08 2 sites Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00135694

    Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 275 participants Est. completion 2015-09 8 sites
    Other conditions: Hepatitis C, Hepatitis C, Chronic, Nonimmune Nonviral Causes of Liver Failure
    View official trial listing →
  • Completed NCT NCT00137436

    Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer

    Not yet reported, Not yet reported Pfizer 93 participants Est. completion 2010-03 24 sites Stand-alone
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT00154284

    Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients

    Not yet reported Novartis 114 participants Est. completion 2008-07 Stand-alone
    Other conditions: Organ Transplantation, Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00169156

    A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma

    Not yet reported Lymphoma Study Association 27 participants Est. completion 2012-11 4 sites Stand-alone
    Other conditions: Untreated T-cell Angioimmunoblastic Lymphoma
    View official trial listing →
  • Completed NCT NCT00187057

    Study for Treatment of Cancer in Children With Ataxia-telangiectasia

    Not yet reported St. Jude Children's Research Hospital 6 participants Est. completion 2013-06 1 site
    Other conditions: Ataxia-Telangiectasia
    View official trial listing →
  • Completed NCT NCT00187070

    Large Cell Lymphoma Pilot Study III

    Not yet reported St. Jude Children's Research Hospital 8 participants Est. completion 2001-07 1 site
    Other conditions: Lymphoma, Large Cell, Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT00187122

    Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma

    Not yet reported St. Jude Children's Research Hospital 42 participants Est. completion 2004-06 1 site
    Other conditions: Lymphoblastic Lymphoma
    View official trial listing →
  • Completed NCT NCT00195429

    A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 47 participants Est. completion 2007-10 1 site
    Other conditions: Kidney Failure, Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT00204659

    Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma

    Not yet reported University Hospital Tuebingen 30 participants Est. completion 2008-09 5 sites
    Other conditions: Primary Gastric Diffuse-Large B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00214279

    MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal

    Not yet reported University of Wisconsin, Madison 32 participants Est. completion 2007-11 1 site Stand-alone
    Other conditions: Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT00244127

    Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.

    Not yet reported Zeneus Pharma 75 participants 5 sites
    Other conditions: Aggressive Non-Hodgkin's Lymphoma in the Elderly.
    View official trial listing →
  • Completed NCT NCT00262405

    Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis

    Not yet reported University of Michigan 44 participants Est. completion 2007-05 1 site
    Other conditions: Idiopathic Pulmonary Fibrosis
    View official trial listing →
  • Terminated NCT NCT00263562

    Steroid Treatment for Sickle Cell Pain Crisis

    Not yet reported Baylor College of Medicine 18 participants Est. completion 2008-06-13 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Vaso-occlusive Crisis
    View official trial listing →
  • Completed NCT NCT00268853

    A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin

    Not yet reported CTI BioPharma 124 participants Est. completion 2012-05 75 sites Stand-alone
    Other conditions: Diffuse Large-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00280774

    Memantine for Corticosteroid-Induced Mood and Declarative Memory Changes

    Not yet reported University of Texas Southwestern Medical Center 20 participants Est. completion 2007-02 1 site
    Other conditions: Physiological Effects of Drugs
    View official trial listing →
  • Completed NCT NCT00283712

    Use of Infliximab for the Treatment of Pemphigus Vulgaris

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 20 participants Est. completion 2011-03 4 sites
    Other conditions: Pemphigus
    View official trial listing →
  • Completed NCT NCT00288080

    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

    Not yet reported Radiation Therapy Oncology Group 612 participants Est. completion 2022-05-20 254 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00292877

    The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)

    Not yet reported St. Joseph's Healthcare Hamilton 20 participants Est. completion 2008-07 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00301821

    Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

    Not yet reported Alliance for Clinical Trials in Oncology 107 participants Est. completion 2015-04 162 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00307671

    Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years

    Not yet reported Assistance Publique - Hôpitaux de Paris 108 participants Est. completion 2011-07 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Vasculitis, Wegener's Granulomatosis, Microscopic Polyangiitis, Churg-Strauss Syndrome
    View official trial listing →
  • Terminated NCT NCT00311311

    Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients

    Not yet reported Pfizer 72 participants Est. completion 2012-01 8 sites Stand-alone
    Other conditions: Atherosclerosis, Kidney Failure
    View official trial listing →
  • Terminated NCT NCT00313482

    PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC

    Not yet reported Veeda Oncology 35 participants Est. completion 2008-08 1 site
    Other conditions: Hormone Refractory Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00320476

    VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates

    Not yet reported Korean Multiple Myeloma Working Party 35 participants Est. completion 2008-02 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00323323

    CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas

    Not yet reported Ohio State University Comprehensive Cancer Center 24 participants Est. completion 2016-10 1 site Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00323960

    Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis

    Not yet reported Istituto Giannina Gaslini 139 participants Est. completion 2015-11-29 1 site
    Other conditions: Juvenile Dermatomyositis
    View official trial listing →
  • Completed NCT NCT00327340

    Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC

    Not yet reported Achieve Life Sciences 70 participants Est. completion 2010-10 10 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT00336414

    Five-Year Actively Controlled Clinical Trial in New Onset Juvenile Systemic Lupus Erythematosus Nephritis

    Not yet reported Istituto Giannina Gaslini Est. completion 2007-06 1 site
    Other conditions: Systemic Lupus Erythematosus Nephritis
    View official trial listing →
  • Terminated NCT NCT00348816

    Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer

    Not yet reported The University of Texas Health Science Center at San Antonio 21 participants Est. completion 2016-07-08 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00352027

    Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma

    Not yet reported St. Jude Children's Research Hospital 81 participants Est. completion 2022-11-15 6 sites Stand-alone
    Other conditions: Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00369356

    Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis

    Not yet reported, Not yet reported Universita di Verona 375 participants Est. completion 2011-01 5 sites Stand-alone
    Cardiovascular disease Other conditions: Ischemic Heart Disease, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00376961

    S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

    Not yet reported SWOG Cancer Research Network 68 participants Est. completion 2017-09 147 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00378326

    Immunotherapy of the Paraneoplastic Syndromes

    Not yet reported Rockefeller University 26 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Paraneoplastic Syndromes
    View official trial listing →
  • Active, not recruiting NCT NCT00379041

    Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 1158 participants
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00384111

    Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular Non Hodgkin's Lymphoma (NHL)

    Not yet reported Spectrum Pharmaceuticals, Inc 26 participants Est. completion 2008-11 6 sites
    Other conditions: Follicular Lymphoma, Lymphoma, Follicular
    View official trial listing →
  • Completed NCT NCT00408005

    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

    Not yet reported National Cancer Institute (NCI) 1895 participants Est. completion 2025-03-31 215 sites Stand-alone
    Other conditions: T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
    View official trial listing →
  • Completed NCT NCT00413920

    Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients

    Not yet reported Novartis 222 participants 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00414414

    A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection

    Not yet reported Ottawa Hospital Research Institute Est. completion 2009-06 2 sites
    Other conditions: Tuberculosis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00417079

    XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer

    Not yet reported Sanofi 755 participants Est. completion 2009-09 26 sites Stand-alone
    Other conditions: Neoplasms, Prostatic Neoplasms
    View official trial listing →
  • Terminated NCT NCT00419536

    Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone

    Not yet reported Novartis Pharmaceuticals 108 participants 3 sites
    Other conditions: Hormone Refractory Prostate Cancer Disease
    View official trial listing →
  • Completed NCT NCT00423098

    Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare

    Not yet reported Novartis Pharmaceuticals 81 participants Est. completion 2009-11 17 sites Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT00433459

    Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

    Not yet reported Christine Mauz-Körholz 2134 participants Est. completion 2013-01 2 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00433940

    Immune Suppression Of Infants Treated With Steroids

    Medical College of Wisconsin 16 participants Est. completion 2010-07 1 site
    Other conditions: Hemangioma
    View official trial listing →
  • Terminated NCT NCT00452361

    Study Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft Recipient

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 31 participants Est. completion 2008-08 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT00452387

    Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)

    Not yet reported Accelerated Community Oncology Research Network 22 participants Est. completion 2009-01 10 sites
    Other conditions: Metastatic Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00459186

    The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer

    Not yet reported, Not yet reported Dana-Farber Cancer Institute 19 participants Est. completion 2012-12 5 sites Stand-alone
    Other conditions: Metastatic, Androgen Independent Prostate Cancer, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00461747

    GEM05 for Patients With Multiple Myeloma Under 65 Years

    Not yet reported PETHEMA Foundation 390 participants Est. completion 2008-12 79 sites
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00466440

    A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients

    Not yet reported Eli Lilly and Company 108 participants Est. completion 2010-06 28 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00466843

    Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

    Not yet reported Office of Rare Diseases (ORD) 54 participants Est. completion 2010-02 4 sites Stand-alone
    Other conditions: Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00473746

    Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer

    Not yet reported, Not yet reported Janssen Research & Development, LLC 66 participants Est. completion 2012-12 3 sites Stand-alone
    Other conditions: Prostate Neoplasms
    View official trial listing →
  • Completed NCT NCT00477750

    Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

    Not yet reported, Not yet reported Mayo Clinic 33 participants Est. completion 2013-08-05 3 sites Stand-alone
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Terminated NCT NCT00486759

    A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

    Not yet reported Hoffmann-La Roche 787 participants Est. completion 2011-11-30 266 sites Stand-alone
    Other conditions: B-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00488982

    Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)

    Not yet reported University of California, San Francisco 125 participants Est. completion 2014-05 4 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00494780

    Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) Patients

    Not yet reported GlaxoSmithKline 59 participants Est. completion 2010-09 1 site
    Other conditions: Lymphoma, Follicular
    View official trial listing →
  • Terminated NCT NCT00503984

    A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

    Not yet reported, Not yet reported University of Miami 22 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Prostate Cancer, Pain
    View official trial listing →
  • Withdrawn NCT NCT00504491

    R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia

    Not yet reported CABYC Est. completion 2012-06 32 sites Stand-alone
    Other conditions: Chronic Lymphocytic Leukaemia, Patients Resistant to a Purine Analogous, Patients Relapsed With Purines Therapy
    View official trial listing →
  • Completed NCT NCT00526175

    LAL-BR/2001: Study Treatment to Low Risk ALL

    Not yet reported PETHEMA Foundation 150 participants Est. completion 2015-12 25 sites
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00531791

    Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation

    Not yet reported Laval University 14 participants Est. completion 2009-09 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT00551291

    A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.

    Not yet reported Hoffmann-La Roche 10 participants Est. completion 2009-06 8 sites Stand-alone
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00562497

    Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)

    Not yet reported Mesoblast, Inc. 192 participants Est. completion 2010-05-20 53 sites
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00579644

    Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate Alone

    Not yet reported University of Nebraska 91 participants Est. completion 2006-05-31 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT00632827

    Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)

    Not yet reported University of California, San Francisco 21 participants Est. completion 2016-06-23 1 site Stand-alone
    Other conditions: Peripheral T-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00634647

    Satraplatin and Prednisone to Treat Prostate Cancer

    Not yet reported National Cancer Institute (NCI) 24 participants Est. completion 2012-05-01 2 sites Stand-alone
    Other conditions: Prostate Cancer, Genetic Polymorphism
    View official trial listing →
  • Withdrawn NCT NCT00636935

    Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)

    Not yet reported George Washington University Est. completion 2013-08 1 site Stand-alone
    Other conditions: Pneumocystis Carinii Pneumonia
    View official trial listing →
  • Completed NCT NCT00650078

    Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis

    Not yet reported Amgen 350 participants Est. completion 2009-05 52 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00650468

    A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

    Not yet reported Astellas Pharma Inc 397 participants Est. completion 2007-12 29 sites Stand-alone
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00663832

    A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer

    Not yet reported Novartis Pharmaceuticals 44 participants 9 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00671034

    Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

    Not yet reported Children's Oncology Group 166 participants Est. completion 2021-03-31 27 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00686335

    A New Modified-release Tablet Formulation of Prednisone (Lodotra®) in Patients With Nocturnal Asthma

    Not yet reported Amgen 12 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Asthma
    View official trial listing →
  • Status unknown NCT NCT00689845

    Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma

    Not yet reported University Hospital Southampton NHS Foundation Trust 120 participants 8 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00702611

    Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis

    Not yet reported Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 133 participants Est. completion 2013-07 48 sites Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00719472

    A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Follicular Non-Hodgkin's Lymphoma (RATE)

    Not yet reported Genentech, Inc. 451 participants Est. completion 2011-05 Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00734149

    Bortezomib With Melphalan and Prednisone for Multiple Myeloma

    Not yet reported Duke University 45 participants Est. completion 2008-02 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT00764907

    Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

    Not yet reported University Hospital, Motol 4000 participants 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Terminated NCT NCT00772668

    Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL

    Not yet reported University of Miami 3 participants Est. completion 2011-02 1 site Stand-alone
    Other conditions: Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma
    View official trial listing →
  • Completed NCT NCT00791947

    A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT

    Not yet reported University of Aarhus 166 participants Est. completion 2010-08 9 sites
    Other conditions: Peripheral T-Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00797810

    Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults

    Not yet reported University of Bologna 25 participants 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00799136

    A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL

    Not yet reported Ontario Clinical Oncology Group (OCOG) 6 participants Est. completion 2013-09 2 sites
    Other conditions: Lymphoma, AIDS Related, HIV Infections
    View official trial listing →
  • Completed NCT NCT00801281

    First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.

    Not yet reported Polish Lymphoma Research Group 250 participants Est. completion 2017-06-25 12 sites Stand-alone
    Other conditions: Follicular Lymphoma, Marginal Zone Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma
    View official trial listing →
  • Completed NCT NCT00801463

    Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis

    Not yet reported Nanjing University School of Medicine 67 participants Est. completion 2011-02 1 site Stand-alone
    Other conditions: Proteinuria, Focal Segmental Glomerulosclerosis
    View official trial listing →
  • Terminated NCT NCT00809341

    R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27 participants Est. completion 2014-04 1 site
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00836810

    Timed Release Tablet Prednisone in Polymyalgia Rheumatica

    Not yet reported, Not yet reported University Hospitals Bristol and Weston NHS Foundation Trust 12 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Polymyalgia Rheumatica
    View official trial listing →
  • Completed NCT NCT00838214

    Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis

    Not yet reported, Not yet reported Dr. Falk Pharma GmbH 208 participants Est. completion 2008-12 1 site
    Other conditions: Autoimmune Hepatitis
    View official trial listing →
  • Terminated NCT NCT00842933

    Adrenal Insufficiency in Septic Shock

    Not yet reported The Methodist Hospital Research Institute 32 participants Est. completion 2011-05 1 site
    Other conditions: Septic Shock, Acute Adrenal Insufficiency
    View official trial listing →
  • Completed NCT NCT00866879

    Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

    Not yet reported Northwestern University 275 participants Est. completion 2019-03 1 site
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT00873093

    Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

    Not yet reported National Cancer Institute (NCI) 148 participants Est. completion 2014-09 171 sites Stand-alone
    Other conditions: B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
    View official trial listing →
  • Status unknown NCT NCT00890253

    Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation

    Not yet reported Armin Goralczyk 29 participants Est. completion 2013-01 1 site
    Other conditions: Liver Transplantation, Chronic Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT00916123

    Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer

    Not yet reported Weill Medical College of Cornell University 15 participants Est. completion 2018-12 2 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00933231

    Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

    Not yet reported Astellas Pharma Inc 281 participants Est. completion 2018-04-03 13 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00953303

    The Effects of Glucocorticoids on Mortality and Renal Function in Patients With Acute Decompensated Heart Failure

    Not yet reported, Not yet reported Hebei Medical University 102 participants Est. completion 2012-01 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT00956059

    Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis

    Not yet reported Xi'an Jiaotong University 40 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Focal Segmental Glomerulosclerosis
    View official trial listing →
  • Active, not recruiting NCT NCT00972478

    Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

    Not yet reported, Not yet reported National Cancer Institute (NCI) 83 participants Est. completion 2027-03-06 190 sites Stand-alone
    Other conditions: Ann Arbor Stage II Non-Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT00973752

    Treatment of Older Adults With Acute Lymphoblastic Leukemia

    Not yet reported Massachusetts General Hospital 30 participants Est. completion 2016-04 3 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00991211

    Bendamustine Plus Rituximab Versus CHOP Plus Rituximab

    Not yet reported University of Giessen 549 participants Est. completion 2009-08 1 site
    Other conditions: Non-Hodgkin Lymphomas, Follicular Lymphomas, Immunocytomas, Lymphocytic Lymphomas, Marginal Zone Lymphomas
    View official trial listing →
  • Terminated NCT NCT01002339

    Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation

    Not yet reported Armando Torres Ramírez 134 participants Est. completion 2015-06 10 sites Stand-alone
    Other conditions: Diabetes Mellitus, Adult-Onset
    View official trial listing →
  • Completed NCT NCT01004991

    Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma

    Not yet reported, Not yet reported Weill Medical College of Cornell University 14 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01014234

    Rapamycin and Regulatory T Cells in Kidney Transplantation

    Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 56 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01055496

    Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma

    Not yet reported Pfizer 103 participants Est. completion 2014-03 28 sites Stand-alone
    Other conditions: Lymphoma, B-Cell
    View official trial listing →
  • Completed NCT NCT01058278

    Impact Post-operative Treatment on Intraocular Pressure Post-SLT on Patients With Primary Open-angle Glaucoma

    Not yet reported CHU de Quebec-Universite Laval 67 participants Est. completion 2015-12 1 site
    Other conditions: Glaucoma, Inflammatory Response
    View official trial listing →
  • Completed NCT NCT01072045

    Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma

    Not yet reported University of Sao Paulo 50 participants Est. completion 2014-12 1 site
    Other conditions: Hemangioma
    View official trial listing →
  • Completed NCT NCT01089322

    Risk Factors Associated to Difficult-to-control Asthma

    Not yet reported Rafael Stelmach 74 participants Est. completion 2009-05-13 1 site Stand-alone
    Other conditions: ASTHMA
    View official trial listing →
  • Completed NCT NCT01092182

    Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 194 participants Est. completion 2023-02-16 30 sites Stand-alone
    Other conditions: Burkitt Lymphoma, Diffuse Large B-cell Lymphoma, c-MYC Positive, Plasmablastic Lymphoma
    View official trial listing →
  • Completed NCT NCT01093196

    Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

    Not yet reported Fondazione EMN Italy Onlus 660 participants Est. completion 2024-07-01 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01107613

    The Lung Attack Alert Study

    Not yet reported University of Alberta 128 participants Est. completion 2013-01 2 sites Stand-alone
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01138657

    Efficacy and Safety of Adalimumab in Patients With Active Uveitis

    Not yet reported AbbVie (prior sponsor, Abbott) 239 participants Est. completion 2014-08 Stand-alone
    Other conditions: Uveitis
    View official trial listing →
  • Terminated NCT NCT01155791

    Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer

    Not yet reported Sandy Srinivas 2 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Urologic Neoplasms, Prostate Cancer, Prostate Cancer Metastatic Disease
    View official trial listing →
  • Completed NCT NCT01160107

    Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients

    Not yet reported Fondazione EMN Italy Onlus 46 participants Est. completion 2022-12-22 Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01183247

    An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens

    Not yet reported University Hospital, Basel, Switzerland 63 participants Est. completion 2010-06 1 site
    Other conditions: Comparative Study, Immunosuppressive Agents
    View official trial listing →
  • Completed NCT NCT01193049

    A Study on the Effects of a Single Dose of Prednisone on Biomarkers of Allergen Responses in Asthmatics (MK-0000-175)

    Not yet reported Merck Sharp & Dohme LLC 11 participants Est. completion 2011-05 Stand-alone
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01199900

    Single Dose Study Of PF-04171327 And Prednisone On Carbohydrate Metabolism

    Not yet reported Pfizer 18 participants Est. completion 2010-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01206452

    Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes

    Not yet reported Dhanunjaya Lakkireddy, MD, FACC 60 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01208766

    Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma

    Not yet reported Stichting Hemato-Oncologie voor Volwassenen Nederland 1503 participants Est. completion 2025-01 208 sites
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01234025

    Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)

    Not yet reported, Not yet reported Ionis Pharmaceuticals, Inc. 113 participants Est. completion 2013-12 38 sites Stand-alone
    Other conditions: Castrate-Resistant Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01239472

    Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant

    Not yet reported Andre Barreto Pereira 30 participants Est. completion 2015-06 1 site
    Other conditions: Renal Transplant Rejection, Immunosuppression
    View official trial listing →
  • Completed NCT NCT01251107

    Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma

    Not yet reported Fondazione Michelangelo 331 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01264315

    Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant

    Not yet reported Fondazione EMN Italy Onlus 53 participants Est. completion 2023-02 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01280617

    Low Dose Thymoglobin in Renal Transplant Patients

    Not yet reported Lahey Clinic 44 participants Est. completion 2014-01 1 site
    Other conditions: Acute Renal Failure
    View official trial listing →
  • Completed NCT NCT01289067

    Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca

    Not yet reported William K. Oh 13 participants Est. completion 2013-05 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01290120

    Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma

    Not yet reported Northern Italy Leukemia Group 182 participants Est. completion 2014-06 12 sites
    Other conditions: Burkitt Lymphoma, B-ALL
    View official trial listing →
  • Terminated NCT NCT01313923

    Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus

    Not yet reported University of California, Irvine 3 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Pemphigus
    View official trial listing →
  • Completed NCT NCT01314118

    IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

    Not yet reported Janssen Biotech, Inc. 131 participants Est. completion 2024-12-02 45 sites Stand-alone
    Other conditions: Prostate Cancer, Prostatic Neoplasm
    View official trial listing →
  • Completed NCT NCT01332097

    Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation

    Not yet reported Mereo BioPharma 183 participants Est. completion 2013-05 6 sites Stand-alone
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01336933

    Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

    Not yet reported University of Nebraska 34 participants Est. completion 2016-12-28 9 sites Stand-alone
    Other conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Peripheral T-cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT01342016

    A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients

    Not yet reported Astellas Pharma Inc 84 participants Est. completion 2013-05 12 sites Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT01345708

    A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia

    Not yet reported Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 23 participants Est. completion 2011-01 2 sites
    Other conditions: Autoimmune Hemolytic Disease (Cold Type) (Warm Type)
    View official trial listing →
  • Completed NCT NCT01358253

    Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia

    Not yet reported Ruijin Hospital 100 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Terminated NCT NCT01390584

    Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

    Not yet reported ECOG-ACRIN Cancer Research Group 6 participants Est. completion 2018-05-18 2 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT01424982

    Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia

    Not yet reported M.D. Anderson Cancer Center 88 participants Est. completion 2027-10-31 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Untreated Adult Acute Lymphoblastic Leukemia
    View official trial listing →
  • Status unknown NCT NCT01430013

    Trial of Endostar Combined With CHOPT for T Cell Lymphoma

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: T Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01448096

    Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma

    Not yet reported Chonbuk National University Hospital 33 participants Est. completion 2019-07-10 1 site Stand-alone
    Other conditions: Large B Cell Diffuse Lymphoma
    View official trial listing →
  • Completed NCT NCT01459887

    Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma

    Not yet reported Shanghai CP Guojian Pharmaceutical Co., Ltd. 278 participants Est. completion 2011-02 1 site
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT01469338

    Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel

    Not yet reported University of Southern California 9 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Diarrhea, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT01478308

    Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer

    Not yet reported New Mexico Cancer Research Alliance Est. completion 2011-10
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01509560

    PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood

    Not yet reported Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 21 participants Est. completion 2016-04-30 1 site Stand-alone
    Other conditions: Condition After Allogenic Peripheral Stem Cell Transplantation (SCT)
    View official trial listing →
  • Completed NCT NCT01517802

    A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

    Not yet reported Janssen Research & Development, LLC 32 participants Est. completion 2021-04-22 22 sites Stand-alone
    Other conditions: Metastatic Castration-resistant Prostate Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01524250

    Optic Neuritis Recovery After Oral or IV Corticosteroids

    Not yet reported, Not yet reported London Health Sciences Centre 51 participants Est. completion 2015-05 2 sites Stand-alone
    Other conditions: Optic Neuritis
    View official trial listing →
  • Withdrawn NCT NCT01539174

    Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated High- or High-Intermediate-Risk Diffuse Large B-Cell Lymphoma

    Not yet reported Fox Chase Cancer Center 1 site Stand-alone
    Other conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01540812

    Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS

    PETHEMA Foundation 418 participants Est. completion 2019-12-01 1 site
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT01553162

    Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia

    Children's Oncology Group 20 participants
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT01619813

    Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer

    Not yet reported Canadian Cancer Trials Group 85 participants Est. completion 2016-05-20 11 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01634061

    Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients

    Not yet reported Novartis Pharmaceuticals 43 participants Est. completion 2015-07 10 sites Stand-alone
    Other conditions: Castration-resistant Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01637402

    A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer

    Not yet reported Terence Friedlander, MD 41 participants Est. completion 2017-02-27 2 sites Stand-alone
    Other conditions: Castration Resistant Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01649635

    Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

    Not yet reported Sanofi 45 participants Est. completion 2016-06 6 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01656187

    Attenuation of Corticosteroid Induced Hippocampal Changes

    Not yet reported University of Texas Southwestern Medical Center 46 participants Est. completion 2017-01 1 site
    Other conditions: Organic Memory Impairment
    View official trial listing →
  • Completed NCT NCT01671423

    Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis

    Not yet reported Albert Einstein Healthcare Network 42 participants Est. completion 2015-09 1 site
    Other conditions: Cellulitis
    View official trial listing →
  • Completed NCT NCT01679860

    Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma

    Not yet reported Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 92 participants Est. completion 2012-08 17 sites Stand-alone
    Other conditions: Lymphoma, T-Cell, Peripheral
    View official trial listing →
  • Status unknown NCT NCT01685125

    Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

    Not yet reported University of Southern California 96 participants Est. completion 2018-03 1 site Stand-alone
    Other conditions: Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01687296

    Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma

    Not yet reported GlaxoSmithKline 261 participants Est. completion 2013-06-21 11 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01717053

    Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer

    Not yet reported Duke University 37 participants Est. completion 2021-08-31 3 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01729494

    Belatacept Early Steroid Withdrawal Trial

    Not yet reported University of Cincinnati 316 participants Est. completion 2019-12 8 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01734759

    Influence of Medication Taste on Pediatric Prescribers' Prescribing Habits

    Not yet reported Mayo Clinic 50 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01735396

    Abiraterone Acetate Trial in African American Prostate Cancer Patients

    Not yet reported Icahn School of Medicine at Mount Sinai 11 participants Est. completion 2016-03 2 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01748500

    Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer

    Not yet reported University Health Network, Toronto 21 participants Est. completion 2021-03 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT01758120

    Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy

    Not yet reported Guangdong Provincial People's Hospital 135 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Status unknown NCT NCT01760096

    Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 50 participants Est. completion 2017-07 1 site Stand-alone
    Other conditions: Paroxysmal Nocturnal Hemoglobinuria, Hemoglobinuria, Hemoglobinuria, Paroxysmal, Proteinuria, Urination Disorders, Thrombosis, Bone Marrow Failure, Aplastic Anemia,, Anemia, Hemolytic
    View official trial listing →
  • Completed NCT NCT01775475

    Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma

    Not yet reported AIDS Malignancy Consortium 7 participants Est. completion 2021-07-15 2 sites
    Other conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, AIDS-related Immunoblastic Large Cell Lymphoma, AIDS-related Lymphoblastic Lymphoma, AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Small Noncleaved Cell Lymphoma, Stage III AIDS-related Lymphoma, Stage IV AIDS-related Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01809444

    Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy

    Not yet reported, Not yet reported Sun Yat-sen University 146 participants Est. completion 2016-01 6 sites Stand-alone
    Other conditions: Thyroid Associated Opthalmopathies
    View official trial listing →
  • Completed NCT NCT01813617

    Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis

    Karolinska University Hospital 72 participants 1 site
    Other conditions: Polymyositis, Dermatomyositis
    View official trial listing →
  • Terminated NCT NCT01828294

    Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis

    Not yet reported St. Louis University 4 participants Est. completion 2017-12 2 sites
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Terminated NCT NCT01845792

    Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer

    Not yet reported University of Colorado, Denver 7 participants Est. completion 2017-02 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01848067

    Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 9 participants Est. completion 2016-06-23 1 site Stand-alone
    Other conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01858922

    Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A

    Not yet reported Baylor College of Medicine 40 participants Est. completion 2019-08-12 1 site Stand-alone
    Other conditions: Hodgkin Disease
    View official trial listing →
  • Completed NCT NCT01859819

    Treatment for Advanced B-Cell Lymphoma

    Not yet reported New York Medical College 45 participants Est. completion 2021-06 5 sites Stand-alone
    Other conditions: Diffuse Large Cell Lymphoma, Burkitt's Lymphoma, High Grade B-cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT01866423

    Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

    Not yet reported University of Southern California 4 participants Est. completion 2016-07-26 1 site
    Other conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01895049

    Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria

    Not yet reported Helio Tedesco Silva Junior 171 participants Est. completion 2017-03-07 1 site Stand-alone
    Other conditions: Kidney Transplantation, Cytomegalovirus
    View official trial listing →
  • Active, not recruiting NCT NCT01920737

    A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

    Not yet reported Memorial Sloan Kettering Cancer Center 39 participants Est. completion 2026-08 3 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT01927588

    Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients

    Not yet reported Fundação Pró Rim 50 participants Est. completion 2015-11 Stand-alone
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT01940094

    The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach

    Not yet reported University of Pennsylvania 159 participants Est. completion 2024-12 9 sites Stand-alone
    Other conditions: Granulomatosis With Polyangiitis
    View official trial listing →
  • Completed NCT NCT01946165

    Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide

    Not yet reported M.D. Anderson Cancer Center 69 participants Est. completion 2017-07-28 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT01949337

    Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 1311 participants Est. completion 2024-08-31 539 sites Stand-alone
    Other conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01958190

    Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus

    Not yet reported Foundation for Liver Research 196 participants Est. completion 2021-05-20 3 sites Stand-alone
    Other conditions: Liver Disease
    View official trial listing →
  • Completed NCT NCT01961843

    Abiraterone Acetate for Castrate Resistant Prostate Cancer

    Not yet reported Massachusetts General Hospital 40 participants Est. completion 2024-05-31 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01994850

    Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients

    Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 32 participants Est. completion 2019-01 1 site Stand-alone
    Other conditions: CD30 Positive Primary Mediastinal Large B-cell Lymphoma, CD30-Positive Diffuse Large B-Cell Lymphoma, CD30-Positive Gray Zone Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT02003222

    Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 488 participants Est. completion 2027-02-25 544 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
    View official trial listing →
  • Completed NCT NCT02012088

    Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb

    Not yet reported Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 91 participants Est. completion 2021-08 14 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT02037191

    The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade

    Not yet reported University Hospital, Rouen 90 participants Est. completion 2017-12 2 sites
    Other conditions: ALOPECIA AREATA
    View official trial listing →
  • Terminated NCT NCT02039115

    Reduction in Symptomatic Esophageal Stricture Formation

    Not yet reported AdventHealth 3 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Esophageal Stenosis
    View official trial listing →
  • Completed NCT NCT02042690

    Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients

    Not yet reported Peking University 131 participants Est. completion 2019-04 5 sites
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Terminated NCT NCT02043587

    Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma

    Not yet reported University of California, San Diego 31 participants Est. completion 2022-04-14 4 sites Stand-alone
    Other conditions: Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT02054559

    R-CHOP Alone vs. R-CHOP Plus Radiotherapy for Localized CD20+ DLBCL

    Not yet reported Asan Medical Center Est. completion 2020-01 1 site Stand-alone
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02072863

    A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma

    Not yet reported, Not yet reported Amgen 9 participants Est. completion 2015-09 8 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02115997

    A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis

    Not yet reported Hoffmann-La Roche 30 participants Est. completion 2022-06-07 10 sites Stand-alone
    Other conditions: Wegener's Granulomatosis or Microscopic Polyangiitis
    View official trial listing →
  • Completed NCT NCT02125357

    Sequencing Abiraterone and Enzalutamide in mCRPC

    Not yet reported British Columbia Cancer Agency 202 participants Est. completion 2020-02-04 7 sites
    Other conditions: Metastatic Castration-Resistant Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02128061

    Efficacy of Lenalidomide in Combination With Subcutaneous Rituximab + miniCHOP in DLBCL Patients of 80 y/o or+

    Not yet reported The Lymphoma Academic Research Organisation 250 participants Est. completion 2021-01 97 sites Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT02145598

    Treatment Optimization in Patients With Untreated Multiple Myeloma

    Not yet reported, Not yet reported Dr. med. Lars-Olof Muegge 85 participants Est. completion 2018-12-31 19 sites
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02149433

    Pneumocystis Jerovici Pneumonia in Infants and Steroids

    Not yet reported Kamuzu University of Health Sciences 78 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Pneumonia, Pneumocystis Jerovici
    View official trial listing →
  • Active, not recruiting NCT NCT02166463

    Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma

    Not yet reported National Cancer Institute (NCI) 600 participants Est. completion 2026-10-03 199 sites Stand-alone
    Other conditions: Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma, Ann Arbor Stage IVB Hodgkin Lymphoma, Childhood Hodgkin Lymphoma, Classic Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT02199184

    Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia

    Not yet reported M.D. Anderson Cancer Center 14 participants Est. completion 2023-02-17 1 site Stand-alone
    Other conditions: AIDS-Related Burkitt Lymphoma, Atypical Burkitt/Burkitt-Like Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements, Recurrent Acute Lymphoblastic Leukemia, Recurrent Burkitt Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Burkitt Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT02205762

    LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

    Not yet reported, Not yet reported North American Consortium for Histiocytosis 1400 participants Est. completion 2026-07 42 sites Stand-alone
    Other conditions: Langerhans Cell Histiocytosis
    View official trial listing →
  • Completed NCT NCT02206425

    Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients

    Not yet reported, Not yet reported Oncotherapeutics 45 participants Est. completion 2018-03-06 12 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT02208791

    Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant

    Not yet reported University of Sao Paulo General Hospital 45 participants Est. completion 2017-07 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT02237820

    Dexamethasone Versus Prednisone in Heart Failure Patients, Hospitalized With Exacerbation of Chronic Obstructive Pulmonary Disease.

    Not yet reported Rabin Medical Center 80 participants Est. completion 2025-06 1 site
    Heart failure Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT02274402

    Pharmacokinetics of Prednisone in Adults

    Assistance Publique - Hôpitaux de Paris 114 participants Est. completion 2016-06 1 site
    Other conditions: Patients Receiving Prednisone
    View official trial listing →
  • Completed NCT NCT02334813

    Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia

    Not yet reported University Hospital, Essen 26 participants Est. completion 2015-01
    Other conditions: Purpura, Thrombocytopenic, Idiopathic
    View official trial listing →
  • Completed NCT NCT02343536

    A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma

    Not yet reported Celgene 59 participants Est. completion 2020-01-29 7 sites Stand-alone
    Other conditions: Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular
    View official trial listing →
  • Status unknown NCT NCT02370550

    Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome

    Not yet reported Peking University People's Hospital 240 participants Est. completion 2021-12 1 site Stand-alone
    Other conditions: Sjogren's Syndrome
    View official trial listing →
  • Status unknown NCT NCT02386332

    A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies

    Instituto de Investigacion Sanitaria La Fe 206 participants Est. completion 2020-03
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Terminated NCT NCT02392286

    Corticosteroid Dosage for Crohn's Disease Flare

    Not yet reported Yale University 15 participants Est. completion 2016-12-19 1 site
    Other conditions: Crohn's Disease, Inflammatory Bowel Disease
    View official trial listing →
  • Status unknown NCT NCT02396043

    Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

    Not yet reported Sun Yat-sen University 50 participants Est. completion 2025-03 1 site Stand-alone
    Other conditions: Lymphoma, Lymphoblastic
    View official trial listing →
  • Status unknown NCT NCT02416674

    Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects

    Not yet reported Brigham and Women's Hospital 10 participants Est. completion 2025-02 1 site Stand-alone
    Other conditions: Abdominal Wall Defect
    View official trial listing →
  • Terminated NCT NCT02419469

    Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

    Not yet reported M.D. Anderson Cancer Center 1 participants Est. completion 2017-06-22 1 site Stand-alone
    Other conditions: Leukemia, Precursor-B Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02449252

    Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Follicular Lymphoma

    Not yet reported Wuhan University 120 participants Est. completion 2025-10 1 site Stand-alone
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02481310

    Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

    Not yet reported, Not yet reported Northwestern University 38 participants Est. completion 2024-07 5 sites Stand-alone
    Other conditions: Adult Burkitt Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma, MYC Gene Mutation, Plasmablastic Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT02494882

    Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older

    Not yet reported Memorial Sloan Kettering Cancer Center 12 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Status unknown NCT NCT02496182

    Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment

    Not yet reported, Not yet reported Grupo Medifarma, S. A. de C. V. 60 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Alveolitis Extrinsic Allergic, Pulmonary Fibrosis
    View official trial listing →
  • Completed NCT NCT02512185

    Towards Optimal Prescription of Chemotherapy in Prostate Cancer

    University Health Network, Toronto 206 participants Est. completion 2019-12-31 4 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02521064

    Effects of Exclusive Enteral Nutrition on the Microbiome in Pediatric Inflammatory Bowel Disease

    McMaster Children's Hospital 31 participants Est. completion 2016-08 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT02528214

    Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma

    Not yet reported Sanofi 210 participants Est. completion 2017-11-13 80 sites Stand-alone
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT02565680

    Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency

    Not yet reported, Not yet reported University Hospital, Toulouse 100 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: Acute Urticaria
    View official trial listing →
  • Completed NCT NCT02573012

    Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants

    Not yet reported Hoffmann-La Roche 314 participants Est. completion 2018-02-09 39 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02614612

    Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

    Not yet reported Incyte Corporation 31 participants Est. completion 2018-08 23 sites Stand-alone
    Other conditions: Graft-versus-host Disease (GVHD)
    View official trial listing →
  • Terminated NCT NCT02631603

    Stop Exogenous Allergic Alveolitis (EAA) in Childhood

    Not yet reported Matthias Griese 4 participants Est. completion 2020-06-16 7 sites
    Other conditions: Hypersensitivity Pneumonitis, Exogenous Allergic Alveolitis
    View official trial listing →
  • Terminated NCT NCT02647255

    Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy

    Not yet reported, Not yet reported Peking University First Hospital 10 participants Est. completion 2020-10 2 sites Stand-alone
    Other conditions: Glomerulonephritis, IGA, Kidney Diseases, Acute Renal Insufficiency, Rapidly Progressive Glomerulonephritis
    View official trial listing →
  • Terminated NCT NCT02656615

    Abiraterone-Rechallenge Study for CRPC Patients

    Not yet reported Aurelius Omlin 4 participants Est. completion 2017-02 3 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02684708

    Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents

    Not yet reported University of Giessen 2921 participants Est. completion 2025-10-31 19 sites Stand-alone
    Other conditions: Classical Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02703376

    Oral Prednisolone in the Treatment of Esophageal Stricture After Esophageal Surgery

    Not yet reported Nagasaki University 8 participants Est. completion 2019-10 1 site
    Other conditions: Esophageal Anastomotic Stricture
    View official trial listing →
  • Terminated NCT NCT02711137

    Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

    Not yet reported, Not yet reported Incyte Corporation 137 participants Est. completion 2019-02-13 18 sites Stand-alone
    Other conditions: Solid Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT02734771

    A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

    Not yet reported Patrick Reagan 24 participants Est. completion 2025-12 2 sites Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02737332

    A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer

    Not yet reported Sun Pharmaceutical Industries Limited 53 participants Est. completion 2017-02-27 17 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02741271

    Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)

    Not yet reported Organon and Co 181 participants Est. completion 2017-12-04 Stand-alone
    Other conditions: Asthma
    View official trial listing →
  • Status unknown NCT NCT02744768

    D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia

    Not yet reported Gruppo Italiano Malattie EMatologiche dell'Adulto 60 participants Est. completion 2021-06 34 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Status unknown NCT NCT02767674

    Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 258 participants Est. completion 2020-12 6 sites
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT02773550

    Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma

    Not yet reported Basque Health Service 24 participants Est. completion 2018-07 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02776436

    Reducing Dexamethasone Around Docetaxel Infusion

    Not yet reported Leiden University Medical Center 46 participants Est. completion 2020-11-20 3 sites Stand-alone
    Other conditions: Breast Cancer, Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT02809079

    Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients

    Not yet reported Third Affiliated Hospital, Sun Yat-Sen University 100 participants Est. completion 2017-12 Stand-alone
    Other conditions: Neuromyelitis Optica Spectrum Disorders, Mycophenolate Mofetil, Efficacy and Safety
    View official trial listing →
  • Completed NCT NCT02809573

    Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients

    Not yet reported Chipscreen Biosciences, Ltd. 30 participants Est. completion 2019-01-08 1 site Stand-alone
    Other conditions: Peripheral T-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02836496

    Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)

    Not yet reported GlaxoSmithKline 108 participants Est. completion 2019-08-08 43 sites Stand-alone
    Other conditions: Hypereosinophilic Syndrome
    View official trial listing →
  • Terminated NCT NCT02844582

    Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

    Not yet reported University of California, Davis 2 participants Est. completion 2019-06-04 1 site Stand-alone
    Other conditions: Hormone-Resistant Prostate Cancer, Stage IV Prostate Adenocarcinoma
    View official trial listing →
  • Terminated NCT NCT02855359

    Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

    Not yet reported Seagen Inc. 24 participants Est. completion 2018-05-15 35 sites Stand-alone
    Other conditions: Diffuse, Large B-Cell, Lymphoma, Follicular Lymphoma, Grade 3b, Transformed Lymphoma / DLBCL
    View official trial listing →
  • Completed NCT NCT02858804

    EDOCH Alternating With DHAP for New Diagnosed Younger MCL

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 55 participants Est. completion 2020-06 1 site Stand-alone
    Other conditions: Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02867020

    Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels

    Not yet reported Latin American Cooperative Oncology Group 128 participants Est. completion 2021-06-30 14 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT02902731

    Giant Cell Arteritis and Anakinra Trial

    Not yet reported University Hospital, Caen 30 participants Est. completion 2022-11-25 1 site
    Other conditions: Giant Cell Arteritis
    View official trial listing →
  • Completed NCT NCT02903160

    Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

    Not yet reported Icahn School of Medicine at Mount Sinai 40 participants Est. completion 2021-11-15 2 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT02918747

    PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage

    Not yet reported Hunan Cancer Hospital 100 participants Est. completion 2021-12 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT02928432

    SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone

    Not yet reported Centro Nacional de Investigaciones Oncologicas CARLOS III 26 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02953873

    Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients

    Not yet reported Medical University of South Carolina 25 participants Est. completion 2018-12-14 1 site
    Other conditions: Immunosuppression
    View official trial listing →
  • Completed NCT NCT02954198

    Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients

    Not yet reported Medical University of South Carolina 40 participants Est. completion 2018-12-27 1 site
    Other conditions: Immunosuppression
    View official trial listing →
  • Completed NCT NCT02985957

    A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)

    Not yet reported Bristol-Myers Squibb 351 participants Est. completion 2025-01-07 59 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT02990403

    The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss

    Not yet reported Shanghai First Maternity and Infant Hospital 500 participants Est. completion 2018-12-22 1 site Stand-alone
    Other conditions: Recurrent Pregnancy Loss
    View official trial listing →
  • Status unknown NCT NCT02996617

    PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia

    Not yet reported Shandong Provincial Hospital 240 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Lymphoma,Non-Hodgkin
    View official trial listing →
  • Status unknown NCT NCT03018626

    R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL

    Not yet reported Nanfang Hospital, Southern Medical University 402 participants Est. completion 2021-01 1 site Stand-alone
    Other conditions: Lymphoma, Large B-Cell, Diffuse
    View official trial listing →
  • Status unknown NCT NCT03023358

    Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients

    Not yet reported Nanfang Hospital, Southern Medical University 174 participants Est. completion 2019-03 1 site Stand-alone
    Other conditions: Peripheral T Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT03036904

    Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas

    Not yet reported Weill Medical College of Cornell University 31 participants Est. completion 2021-11-11 6 sites Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT03093272

    A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer

    Not yet reported Dana-Farber Cancer Institute 9 participants Est. completion 2019-12-31 2 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT03110588

    Phase I Trial of PACE for Metastatic Prostate Cancer

    Not yet reported University of Alabama at Birmingham Est. completion 2019-12-18 1 site Stand-alone
    Other conditions: Metastatic Prostate Cancer
    View official trial listing →
  • Completed NCT NCT03129828

    Ibrutinib, Bortezomib and Rituximab-CHOP for the Treatment of Elderly Patients With CD20+ DLBCL, IPI ≥ 2

    Not yet reported, Not yet reported Prof. Dr. Clemens Schmitt 38 participants Est. completion 2024-11-12 1 site Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT03139604

    GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease

    Not yet reported Incyte Corporation 439 participants Est. completion 2020-07-13 129 sites Stand-alone
    Other conditions: Graft-versus-host Disease (GVHD)
    View official trial listing →
  • Completed NCT NCT03141970

    Prednisolone Trial in Children Younger Than 4 Years

    Not yet reported All India Institute of Medical Sciences 170 participants Est. completion 2021-10-31 5 sites
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Terminated NCT NCT03145480

    Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients

    Not yet reported Northwell Health 3 participants Est. completion 2018-09-28 1 site Stand-alone
    Other conditions: Richter Syndrome
    View official trial listing →
  • Terminated NCT NCT03225924

    Study of Entospletinib (ENTO) in Newly Diagnosed DLBCL Patients With aaIPI>=1 Treated by Chemiotherapy

    Not yet reported, Not yet reported The Lymphoma Academic Research Organisation 25 participants Est. completion 2019-10-18 27 sites Stand-alone
    Other conditions: DLBCL
    View official trial listing →
  • Completed NCT NCT03263650

    Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

    Not yet reported M.D. Anderson Cancer Center 96 participants Est. completion 2026-06-10 1 site Stand-alone
    Other conditions: Prostate Cancer Aggressiveness, Prostate Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT03269669

    Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

    Not yet reported National Cancer Institute (NCI) 73 participants Est. completion 2027-01-21 429 sites
    Other conditions: Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma, Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma
    View official trial listing →
  • Status unknown NCT NCT03273452

    Chidamide With PET Regimen for Angioimmunoblastic T Cell Lymphoma (PET: Prednisone, Etoposide and Thalidomide)

    Not yet reported Qingdao University 30 participants Est. completion 2019-05 1 site Stand-alone
    Other conditions: Angioimmunoblastic T-cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT03293173

    Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis

    Not yet reported Nordic Lymphoma Group 120 participants Est. completion 2024-12-31 16 sites Stand-alone
    Other conditions: Lymphoma, Large B-Cell, Diffuse
    View official trial listing →
  • Status unknown NCT NCT03318835

    Thalidomide Combined With R-CHOP in Newly Diagnosed，Untreated Double-expressor Diffuse Large B-Cell Lymphoma Patients

    Not yet reported Fudan University 162 participants Est. completion 2020-08-22 1 site Stand-alone
    Other conditions: Thalidomide
    View official trial listing →
  • Active, not recruiting NCT NCT03323476

    Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease

    Not yet reported Centre Hospitalier Departemental Vendee 136 participants Est. completion 2031-03 57 sites
    Other conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT03335956

    CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)

    Not yet reported Corcept Therapeutics 48 participants Est. completion 2018-06-25 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03338790

    An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer

    Not yet reported Bristol-Myers Squibb 292 participants Est. completion 2025-01-10 66 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT03356444

    Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the Prostate

    Not yet reported West China Hospital 140 participants Est. completion 2020-12 Stand-alone
    Other conditions: Prostate Cancer, Castration-resistant Prostate Cancer, Drug
    View official trial listing →
  • Status unknown NCT NCT03356912

    CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy

    Not yet reported Consorzio Oncotech 220 participants Est. completion 2021-05-04 1 site
    Other conditions: Prostate Cancer, Castration-resistant Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03431350

    A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer

    Not yet reported Janssen Research & Development, LLC 136 participants Est. completion 2026-12-31 50 sites Stand-alone
    Other conditions: Prostatic Neoplasms, Castration-Resistant
    View official trial listing →
  • Status unknown NCT NCT03449719

    Phase II Randomized Trial of Radiation Therapy in Oligometastatic mCRPC Prostate Cancer (ARTO)

    Not yet reported Lorenzo Livi 174 participants Est. completion 2022-05-01 Stand-alone
    Other conditions: Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone
    View official trial listing →
  • Active, not recruiting NCT NCT03463057

    The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL

    Not yet reported Stichting Hemato-Oncologie voor Volwassenen Nederland 109 participants Est. completion 2027-01 32 sites
    Other conditions: NHL, DLBCL
    View official trial listing →
  • Completed NCT NCT03485118

    RHCACD20MA (HS006) Combined With CHOP (Hi-CHOP) in Patients With Previously Untreated Diffuse Large B-cell Lymphoma

    Not yet reported Zhejiang Hisun Pharmaceutical Co. Ltd. 137 participants Est. completion 2018-01-14 Stand-alone
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT03551782

    A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer

    Not yet reported Janssen Research & Development, LLC 33 participants Est. completion 2021-11-11 34 sites Stand-alone
    Other conditions: Castration-Resistant Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT03553472

    Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster

    University of Wisconsin, Madison 97 participants Est. completion 2019-05-31 1 site
    Other conditions: Herpes Zoster, Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT03564704

    Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 80 participants Est. completion 2021-05-30 1 site Stand-alone
    Other conditions: Leukemia, Leukemia, Acute, Adult Lymphoblastic Lymphoma, Leukemia, Lymphoblastic, Leukemia, T Cell, Adult Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT03585556

    AAVCAGsCD59 for the Treatment of Wet AMD

    Not yet reported Janssen Research & Development, LLC 25 participants Est. completion 2022-01-18 2 sites Stand-alone
    Other conditions: Wet Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT03625219

    Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers

    Not yet reported Innovaderm Research Inc. 54 participants Est. completion 2020-06-09 1 site
    Other conditions: Delayed Type Hypersensitivity
    View official trial listing →
  • Completed NCT NCT03632187

    Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS

    Not yet reported University Hospital, Brest 34 participants Est. completion 2022-06-23 5 sites
    Other conditions: Polymyalgia Rheumatica
    View official trial listing →
  • Status unknown NCT NCT03650933

    A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

    Not yet reported Nanjing Yoko Biomedical Co., Ltd. 360 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma, Unspecified Site
    View official trial listing →
  • Completed NCT NCT03656926

    Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

    Not yet reported Zambon SpA 169 participants Est. completion 2024-03-12 40 sites
    Other conditions: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
    View official trial listing →
  • Active, not recruiting NCT NCT03663933

    Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation

    Not yet reported National Cancer Institute (NCI) 71 participants Est. completion 2030-04-03 2 sites Stand-alone
    Other conditions: Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders, Immune System Diseases, Common Variable Immunodeficiency
    View official trial listing →
  • Status unknown NCT NCT03671174

    Immunosuppressant Regimens for Living Fetuses Study

    Not yet reported RenJi Hospital 420 participants Est. completion 2023-02 1 site Stand-alone
    Other conditions: Undifferentiated Connective Tissue Disease, Recurrent Pregnancy Loss
    View official trial listing →
  • Status unknown NCT NCT03692416

    The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in Children

    Not yet reported Assiut University 70 participants Est. completion 2022-05-11 1 site
    Other conditions: Vasculitis
    View official trial listing →
  • Active, not recruiting NCT NCT03732820

    Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer

    Not yet reported AstraZeneca 895 participants Est. completion 2027-02-05 132 sites Stand-alone
    Other conditions: Metastatic Castration-resistant Prostate Cancer
    View official trial listing →
  • Completed NCT NCT03761225

    Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer

    Not yet reported AB Science 714 participants Est. completion 2020-12-15 9 sites Stand-alone
    Other conditions: Metastatic Castrate Resistant Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT03762265

    A Study of PRN1008 in Patients With Pemphigus

    Not yet reported Principia Biopharma, a Sanofi Company 131 participants Est. completion 2021-12-17 88 sites Stand-alone
    Other conditions: Pemphigus
    View official trial listing →
  • Completed NCT NCT03782532

    Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma

    Not yet reported Sanofi 486 participants Est. completion 2022-05-21 67 sites Stand-alone
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT03790332

    Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

    Not yet reported, Not yet reported Pharmacyclics LLC. 59 participants Est. completion 2025-10-09 48 sites
    Other conditions: Chronic Graft Versus Host Disease
    View official trial listing →
  • Status unknown NCT NCT03791827

    Multicenter Registry of Pediatric Lupus Nephritis in China

    Xiqiang Dang 1200 participants Est. completion 2024-11-30 1 site
    Other conditions: Lupus Nephritis, Children, Steroid, Immunosuppressive Treatment
    View official trial listing →
  • Completed NCT NCT03823768

    Envarsus Neurotoxicity Burden in Liver Transplant Patients

    Not yet reported Medical University of South Carolina 30 participants Est. completion 2024-01-30 1 site Stand-alone
    Other conditions: Neurotoxicity, Liver Transplant; Complications
    View official trial listing →
  • Completed NCT NCT03834506

    Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)

    Not yet reported Merck Sharp & Dohme LLC 1030 participants Est. completion 2023-07-18 215 sites Stand-alone
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT03892785

    MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial

    Not yet reported Centre Hospitalier Universitaire Dijon 230 participants Est. completion 2027-01 1 site Stand-alone
    Other conditions: Giant Cell Arteritis
    View official trial listing →
  • Active, not recruiting NCT NCT03943901

    Split-Dose R-CHOP for Older Adults With DLBCL

    Not yet reported University of Wisconsin, Madison 27 participants Est. completion 2027-02 1 site Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma, DLBCL, Cancer
    View official trial listing →
  • Status unknown NCT NCT03974867

    Vestibular Prognosis Assessment of ISSNHL With Vestibular Dysfunction Treated With Oral or Intratympanic Glucocorticoids

    Not yet reported Eye & ENT Hospital of Fudan University 72 participants Est. completion 2020-12 1 site Stand-alone
    Substance use disorder Other conditions: Vestibular Vertigo
    View official trial listing →
  • Active, not recruiting NCT NCT03984448

    Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas

    Not yet reported, Not yet reported National Cancer Institute (NCI) 363 participants Est. completion 2028-04-01 634 sites Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double-Expressor Lymphoma, EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma, Not Otherwise Specified, Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present, Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT03991884

    Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

    Not yet reported University of Washington 24 participants Est. completion 2023-06-28 1 site Stand-alone
    Other conditions: Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma, Refractory B Acute Lymphoblastic Leukemia, Refractory B Lymphoblastic Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04020328

    Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency

    Not yet reported Shenzhen Second People's Hospital 70 participants Est. completion 2022-05-31 1 site Stand-alone
    Other conditions: Glomerulonephritis, IGA, Renal Insufficiency, Chronic
    View official trial listing →
  • Status unknown NCT NCT04023916

    Sintilimab Plus R-CHOP as the First-line Treatment in Patients With Diffuse Large B-Cell Lymphoma.

    Not yet reported Chinese Academy of Medical Sciences 30 participants Est. completion 2021-07-30 Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma, Sintilimab, TP53 Mutation
    View official trial listing →
  • Completed NCT NCT04056754

    Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate Cancer

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 268 participants Est. completion 2019-07-16 16 sites Stand-alone
    Other conditions: Metastatic Castration Resistant Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT04101578

    Clinical Prognosis and Progression of Myasthenia Gravis Patients

    Da, Yuwei, M.D. 2000 participants Est. completion 2024-12-31 1 site
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Status unknown NCT NCT04139772

    Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.

    Not yet reported National Cancer Institute, Naples 18 participants Est. completion 2024-07-01 1 site Stand-alone
    Other conditions: Metastatic Castration-resistent Prostate Cancer
    View official trial listing →
  • Completed NCT NCT04164368

    Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients

    Not yet reported Fudan University 67 participants Est. completion 2023-08-30 1 site Stand-alone
    Other conditions: Double Expressor Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT04221477

    A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis

    Not yet reported Hoffmann-La Roche 271 participants Est. completion 2031-03-02 74 sites Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT04225988

    Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients

    Not yet reported Cedars-Sinai Medical Center 20 participants Est. completion 2023-07-11 1 site Stand-alone
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Terminated NCT NCT04234360

    Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation

    Not yet reported University Hospital, Montpellier 182 participants Est. completion 2025-01-30 18 sites Stand-alone
    Other conditions: COPD Exacerbation
    View official trial listing →
  • Status unknown NCT NCT04239196

    Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA

    Not yet reported Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 58 participants Est. completion 2022-12-10 10 sites Stand-alone
    Other conditions: Giant Cell Arteritis, Optic Ischaemic Neuropathy
    View official trial listing →
  • Terminated NCT NCT04311567

    Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease

    Not yet reported Vastra Gotaland Region 3 participants Est. completion 2024-03-26 3 sites Stand-alone
    Other conditions: Rheumatoid Arthritis, Interstitial Lung Disease Due to Systemic Disease (Disorder), RA, ILD
    View official trial listing →
  • Completed NCT NCT04374929

    Subcostal Temporary Extracardiac Pacing II Study

    Not yet reported AtaCor Medical, Inc. 7 participants Est. completion 2021-05-14 2 sites
    Other conditions: Conduction Defect
    View official trial listing →
  • Status unknown NCT NCT04380818

    Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19

    Not yet reported Grupo de Investigación Clínica en Oncología Radioterapia 106 participants Est. completion 2021-11-01 3 sites Stand-alone
    Other conditions: Pneumonia, Viral
    View official trial listing →
  • Status unknown NCT NCT04409691

    SCMC Trial on KHE With KMP (V.2020)

    Not yet reported Shanghai Children's Medical Center 20 participants Est. completion 2023-06-30 1 site Stand-alone
    Other conditions: Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)
    View official trial listing →
  • Completed NCT NCT04410536

    Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency

    Not yet reported Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 25 participants Est. completion 2022-07-31 1 site
    Other conditions: Migraine, Hemicrania
    View official trial listing →
  • Active, not recruiting NCT NCT04446117

    Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

    Not yet reported Exelixis 575 participants Est. completion 2026-10-16 280 sites
    Other conditions: Metastatic Prostate Cancer, Prostate Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04484506

    Pegaspargase-COEP Chemotherapy Combined With Radiotherapy for Extra-nodal NK/T Cell Lymphoma

    Not yet reported Peking University 150 participants Est. completion 2025-12-30 1 site Stand-alone
    Other conditions: NK/T Cell Lymphoma Nos
    View official trial listing →
  • Active, not recruiting NCT NCT04497844

    A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

    Not yet reported Janssen Research & Development, LLC 696 participants Est. completion 2027-11-01 387 sites Stand-alone
    Other conditions: Metastatic Castration-sensitive Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT04534478

    Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19

    Not yet reported Hospital Universitari Vall d'Hebron Research Institute 120 participants Est. completion 2021-12-15
    Other conditions: COVID-19 Pneumonia
    View official trial listing →
  • Active, not recruiting NCT NCT04540380

    Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH

    Not yet reported Massachusetts General Hospital 20 participants Est. completion 2027-06 1 site
    Other conditions: Renal Failure
    View official trial listing →
  • Active, not recruiting NCT NCT04542824

    Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)

    Not yet reported, Not yet reported Genmab 78 participants Est. completion 2027-09 15 sites Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma, Small Lymphocytic Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04544059

    Lenalidomide Plus R-CHOP for CNS Relapse Prophylaxis in Diffuse Large B-cell Lymphoma

    Not yet reported Nanfang Hospital, Southern Medical University 87 participants Est. completion 2024-10-01 1 site Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04558268

    Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss

    Not yet reported, Not yet reported Soroka University Medical Center 242 participants Est. completion 2021-10 1 site Stand-alone
    Other conditions: Recurrent Pregnancy Loss(RPL), Recurrent Miscarriage
    View official trial listing →
  • Status unknown NCT NCT04569890

    Treatment of Pregnancy RA

    Not yet reported RenJi Hospital 100 participants Est. completion 2023-12-01 1 site
    Other conditions: Rheumatoid Arthritis, Pregnancy Related
    View official trial listing →
  • Completed NCT NCT04658927

    Dextenza With ILUX for Treatment of MGD

    Not yet reported Warrenville Eyecare 30 participants Est. completion 2021-05-30 1 site
    Other conditions: Meibomian Gland Dysfunction, Evaporative Dry Eye
    View official trial listing →
  • Status unknown NCT NCT04660565

    Belimumab Treatment for IgG4-related Disease

    Not yet reported Peking Union Medical College Hospital 60 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: IgG4-related Disease
    View official trial listing →
  • Completed NCT NCT04660799

    A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL)

    Not yet reported Hoffmann-La Roche 50 participants Est. completion 2022-10-11 8 sites Stand-alone
    Other conditions: Lymphoma, Large B-Cell, Diffuse
    View official trial listing →
  • Terminated NCT NCT04677855

    Study of PCUR-101 in Combination With ADT in Patients With mCRPC

    Not yet reported Pellficure Pharmaceuticals, Inc 7 participants Est. completion 2023-11-20 4 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT04736108

    Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate

    Not yet reported West China Hospital 50 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04739813

    Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 34 participants Est. completion 2031-06-18 1 site Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Burkitt Lymphoma
    View official trial listing →
  • Completed NCT NCT04799262

    Tofacitinib as a GC Sparing Agent for Polymyalgia Rheumatica

    Not yet reported RenJi Hospital 14 participants Est. completion 2022-05-01 1 site Stand-alone
    Other conditions: Polymyalgia Rheumatica, Effect of Drug, Safety Issues
    View official trial listing →
  • Status unknown NCT NCT04810156

    Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis

    Not yet reported Inge Marie Svane 60 participants Est. completion 2025-11-07 5 sites
    Other conditions: Hepatitis, Drug-Induced
    View official trial listing →
  • Enrolling by invitation NCT NCT04833907

    rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease

    Not yet reported, Not yet reported Myrtelle Inc. 24 participants Est. completion 2027-08-31 1 site Stand-alone
    Other conditions: Canavan Disease
    View official trial listing →
  • Status unknown NCT NCT04835870

    Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL

    Not yet reported The First Affiliated Hospital of Soochow University 78 participants Est. completion 2025-10-01 16 sites Stand-alone
    Other conditions: Non-GCB/ABC Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04842318

    Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study

    Not yet reported Ruijin Hospital 789 participants Est. completion 2024-03-01 1 site Stand-alone
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04849533

    Belatacept With Early Steroid Withdrawal rATG and Everolimus in Renal Transplantation (BETTER Trial)

    Not yet reported University of Cincinnati 120 participants Est. completion 2024-07 2 sites
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Active, not recruiting NCT NCT04884035

    Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

    Not yet reported Celgene 224 participants Est. completion 2028-12-01 36 sites Stand-alone
    Other conditions: Lymphoma, B-Cell
    View official trial listing →
  • Completed NCT NCT04887506

    TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

    Not yet reported Tavanta Therapeutics 107 participants Est. completion 2022-10-20 42 sites Stand-alone
    Other conditions: Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-sensitive Prostate Cancer, Metastatic Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT04903054

    Selective CD28 Blockade in Renal Transplant Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2022-09-22 1 site Stand-alone
    Other conditions: Kidney Transplantation, Renal Transplant Recipients
    View official trial listing →
  • Status unknown NCT NCT04942314

    Practice of Treat-to-target on Pediatric Systemic Lupus Erythematosus: a Two-center Retrospective Study

    Jia Deng 600 participants Est. completion 2023-06-01
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT04943146

    An Assessment of Aspirin Plus Prednisone Treatment for Euthyroid Women With Thyroid Autoimmunity

    Second Affiliated Hospital, Zhejiang University, School of Medicine 402 participants Est. completion 2022-03 2 sites
    Other conditions: Thyroid Diseases
    View official trial listing →
  • Withdrawn NCT NCT04974996

    A Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Antitumor Activity of Loncastuximab Tesirine in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated Diffuse Large B-cell Lymphoma (LOTIS-8)

    Not yet reported ADC Therapeutics S.A. Est. completion 2027-05-05 1 site Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04987450

    Effect of Glucocorticoids on Inflammation and Bone Metabolism in Patients With Glomerular Disease

    Medical University of Lodz 40 participants Est. completion 2021-07-30 1 site
    Other conditions: Glomerular Disease
    View official trial listing →
  • Completed NCT NCT05024448

    Glucocorticosteroid Treatment in Acute Unilateral Vestibulopathy (Vestibular Neuronitis)

    Not yet reported University Hospital, Geneva 96 participants Est. completion 2021-06-09
    Other conditions: Acute Peripheral Vestibulopathy
    View official trial listing →
  • Completed NCT NCT05051891

    A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma

    Not yet reported Beijing InnoCare Pharma Tech Co., Ltd. 3 participants Est. completion 2025-06-30 22 sites Stand-alone
    Other conditions: Treatment-naїve Mantle Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT05059873

    Treatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil Levels

    Not yet reported Capital Medical University 11 participants Est. completion 2024-05-31 1 site Stand-alone
    Other conditions: Acute Exacerbation of COPD, Corticosteroid, Morality, Lung Diseases, Obstructive, Blood Eosinophil Count, COPD, Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Terminated NCT NCT05084859

    A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

    Not yet reported Biosplice Therapeutics, Inc. 30 participants Est. completion 2022-10-20 20 sites Stand-alone
    Other conditions: Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, Colorectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05171816

    Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)

    Not yet reported AstraZeneca 110 participants Est. completion 2027-02-05 26 sites Stand-alone
    Other conditions: Metastatic Castration-resistant Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT05188911

    Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial

    Fudan University 30 participants Est. completion 2022-07-15 1 site
    Other conditions: Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Disease
    View official trial listing →
  • Status unknown NCT NCT05189197

    A Study to Evaluate Efficacy and Safety of Zanubrutinib With R-CHOP in Newly Diagnosed Non-GCB DLBCL Patients With Double Expression

    Not yet reported Fudan University 41 participants Est. completion 2026-01 1 site Stand-alone
    Other conditions: Diffuse Large B-cell Lymphoma(DLBCL)
    View official trial listing →
  • Status unknown NCT NCT05223582

    Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial

    Not yet reported Fudan University 34 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: High-risk Prostate Cancer, Neoadjuvant Therapy
    View official trial listing →
  • Status unknown NCT NCT05244642

    A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma

    Not yet reported Akeso 60 participants Est. completion 2026-03-30 6 sites
    Other conditions: Hodgkin Disease Lymphoma
    View official trial listing →
  • Status unknown NCT NCT05290090

    ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL

    Not yet reported Zhejiang Cancer Hospital 31 participants Est. completion 2025-12-01 1 site Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT05326516

    A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia

    Not yet reported Syndax Pharmaceuticals 30 participants Est. completion 2024-07-29 11 sites Stand-alone
    Other conditions: Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Mixed Phenotype Acute Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia
    View official trial listing →
  • Completed NCT NCT05371054

    Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies

    Not yet reported, Not yet reported National Cancer Institute (NCI) 8 participants Est. completion 2025-12-16 1 site Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin Lymphoma, NHL, Hematologic Malignancies, Lymphoid Malignancies
    View official trial listing →
  • Active, not recruiting NCT NCT05371093

    Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma

    Not yet reported Kite, A Gilead Company 231 participants Est. completion 2030-10 52 sites
    Other conditions: Relapsed/Refractory Follicular Lymphoma
    View official trial listing →
  • Approved For Marketing NCT NCT05401214

    Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

    Janssen Research & Development, LLC
    Other conditions: Metastatic Castration-resistant Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05455697

    Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma

    Not yet reported, Not yet reported University of Washington 33 participants Est. completion 2027-01-07 1 site Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT05457257

    Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

    Not yet reported AstraZeneca 43 participants Est. completion 2026-12-31 35 sites
    Other conditions: Metastatic Castration-resistant Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT05459649

    Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia

    Not yet reported Peking University People's Hospital 253 participants Est. completion 2025-07-20 1 site Stand-alone
    Other conditions: Immune Thrombocytopenia
    View official trial listing →
  • Status unknown NCT NCT05466175

    A Study of Olverembatinib in the Treatment of Ph+ ALL

    Not yet reported Chen Suning 55 participants Est. completion 2024-09-30 1 site Stand-alone
    Other conditions: Philadelphia-Positive ALL
    View official trial listing →
  • Status unknown NCT NCT05506033

    Optimization of Glucocorticoid Taper Strategies for SLE-ITP

    Not yet reported Fujian Medical University Union Hospital 120 participants Est. completion 2025-12-01 1 site Stand-alone
    Other conditions: Lupus Erythematosus, Systemic, Purpura, Thrombocytopenic, Idiopathic, Glucocorticoids, Adverse Effect of Glucocorticoids
    View official trial listing →
  • Status unknown NCT NCT05522465

    Short-course High-dose Prednisone and Dexamethasone in Children With ITP

    Not yet reported Fujian Medical University Union Hospital 608 participants Est. completion 2026-08-31 1 site Stand-alone
    Other conditions: Immune Thrombocytopenia, Glucocorticoids, Child, Only
    View official trial listing →
  • Status unknown NCT NCT05525065

    Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBDs)

    Premier Specialists, Australia 138 participants Est. completion 2025-09-01 1 site
    Other conditions: Autoimmune Bullous Dermatosis, Glucocorticoids Toxicity
    View official trial listing →
  • Status unknown NCT NCT05527912

    A Phase II Study of Rituximab, Chidamide, Zanubrutinib-induced and CHOP Therapy

    Not yet reported Sun Yat-sen University 45 participants Est. completion 2024-12-01 2 sites Stand-alone
    Other conditions: Double Express Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT05591144

    Short-term Oral Prednisone for Acute Subjective Tinnitus

    Not yet reported Eye & ENT Hospital of Fudan University 146 participants Est. completion 2024-02-03 1 site Stand-alone
    Other conditions: Tinnitus, Subjective
    View official trial listing →
  • Active, not recruiting NCT NCT05603468

    Effect of PRP vs Corticosteroid in Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 387 participants Est. completion 2027-12-31 1 site
    Other conditions: Tendinopathy
    View official trial listing →
  • Status unknown NCT NCT05625581

    Tofatib Treatment for IgG4-related Disease

    Changhai Hospital 40 participants Est. completion 2025-12-31 1 site
    Other conditions: IgG4-related Disease
    View official trial listing →
  • Status unknown NCT NCT05644210

    Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE

    Qilu Hospital of Shandong University 80 participants Est. completion 2025-12-30 1 site
    Other conditions: Antiphospholipid Syndrome
    View official trial listing →
  • Status unknown NCT NCT05667896

    Prognostic Model of GC/TAC in the Treatment of MN

    Qianfoshan Hospital 50 participants Est. completion 2023-12
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Active, not recruiting NCT NCT05673785

    A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)

    Not yet reported Takeda 52 participants Est. completion 2027-12-31 16 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Enrolling by invitation NCT NCT05678933

    AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 200 participants Est. completion 2029-12-01 1 site Stand-alone
    Other conditions: Peripheral T-cell Lymphoma Targeted Therapy
    View official trial listing →
  • Withdrawn NCT NCT05740449

    HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

    Not yet reported, Not yet reported Princess Maxima Center for Pediatric Oncology Est. completion 2029-10-01 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory
    View official trial listing →
  • Not yet recruiting NCT NCT05746689

    Study of Sirolimus in IgG4-related Disease

    Not yet reported Peking University International Hospital 20 participants Est. completion 2028-12-31 Stand-alone
    Other conditions: IgG4-related Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05761171

    A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

    Not yet reported Children's Oncology Group 78 participants Est. completion 2027-12-31 84 sites Stand-alone
    Other conditions: Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage, Recurrent Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged, Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Refractory Acute Leukemia of Ambiguous Lineage, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage, Refractory Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged, Refractory Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia, Refractory Mixed Phenotype Acute Leukemia
    View official trial listing →
  • Status unknown NCT NCT05777369

    R-CMOP in Patients With Primary Diffuse Large B-cell Lymphoma

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 30 participants Est. completion 2024-08 Stand-alone
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT05782933

    Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy

    Not yet reported Beijing Friendship Hospital 2 participants Est. completion 2023-12-04 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Status unknown NCT NCT05809011

    Efficacy and Safety of corticoSTEROids Added to Standard Therapy in Patients With Acute Heart Failure (STERO-AHF)

    Not yet reported, Not yet reported Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 120 participants Est. completion 2025-12 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05830747

    Effect of Pre-emptive Dose of Prednisone Versus Placebo in Impacted Third Molar Surgery

    Not yet reported University Magna Graecia 34 participants Est. completion 2022-12-10 1 site Stand-alone
    Other conditions: Facial Swelling, Tooth Position Anomalies, Tooth, Impacted, Tooth Extraction Status Nos, Tooth Avulsion
    View official trial listing →
  • Active, not recruiting NCT NCT05888493

    A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma

    Not yet reported Novartis Pharmaceuticals 109 participants Est. completion 2031-02-20 30 sites
    Other conditions: Follicular Lymphoma (FL)
    View official trial listing →
  • Status unknown NCT NCT05896813

    CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 30 participants Est. completion 2025-01-01 1 site Stand-alone
    Other conditions: Newly Diagnosed Peripheral T-cell Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT05934097

    FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma

    Not yet reported Fate Therapeutics Est. completion 2039-05 Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma, Transformed Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
    View official trial listing →
  • Status unknown NCT NCT05969743

    Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host Disease

    Not yet reported Rabin Medical Center 42 participants Est. completion 2025-07-31 Stand-alone
    Other conditions: Graft-versus-host-disease, CMV
    View official trial listing →
  • Completed NCT NCT05975450

    Subcutaneous Abatacept in Renal Transplant Recipients

    Not yet reported Idelberto Badell 16 participants Est. completion 2025-02-14 2 sites Stand-alone
    Other conditions: Kidney Transplant Recipient
    View official trial listing →
  • Active, not recruiting NCT NCT06040320

    Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)

    Not yet reported, Not yet reported Washington University School of Medicine 12 participants Est. completion 2032-05-31 1 site Stand-alone
    Other conditions: Post-transplant Lymphoproliferative Disorder
    View official trial listing →
  • Enrolling by invitation NCT NCT06126380

    Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients

    Not yet reported Eledon Pharmaceuticals 132 participants Est. completion 2029-12 43 sites Stand-alone
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT06145126

    Effects of Glucocortioids in Human Skeletal Muscle, Adipose Tissue and Skin

    Not yet reported University of Aarhus 12 participants Est. completion 2025-07
    Other conditions: Glucocorticoids Toxicity, Iatrogenic Effect
    View official trial listing →
  • Completed NCT NCT06172361

    Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica

    Not yet reported Zhejiang University 104 participants Est. completion 2026-05-30 1 site Stand-alone
    Other conditions: Polymyalgia Rheumatica
    View official trial listing →
  • Completed NCT NCT06236152

    Steroids vs Placebo in Treatment of Tuberculous Lymphadenitis

    Not yet reported Fahad Javed Awan 140 participants Est. completion 2023-08-15 1 site
    Other conditions: Tuberculous Lymphadenitis, Cervical
    View official trial listing →
  • Not yet recruiting NCT NCT06255704

    A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle CellLymphoma Patients

    Not yet reported Shanxi Province Cancer Hospital 23 participants Est. completion 2027-12-01 1 site Stand-alone
    Other conditions: Mantle Cell Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT06313996

    A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma

    Not yet reported Juno Therapeutics, Inc., a Bristol-Myers Squibb Company Est. completion 2031-10-16
    Other conditions: Relapsed or Refractory Follicular Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT06388564

    A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

    Not yet reported Incyte Corporation 130 participants Est. completion 2029-12-01 68 sites
    Other conditions: Chronic Graft-versus-host-disease
    View official trial listing →
  • Withdrawn NCT NCT06392841

    Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations

    Not yet reported Qian Qin Est. completion 2029-01-31 Stand-alone
    Other conditions: Metastatic Hormone-sensitive Prostate Cancer (mHSPC), Deleterious HRR Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation, BRIP1 Gene Mutation, CHEK2 Gene Mutation, FANCA Gene Mutation, PALB2 Gene Mutation, RAD51B Gene Mutation, RAD54L Gene Mutation
    View official trial listing →
  • Not yet recruiting NCT NCT06516978

    A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 528 participants Est. completion 2029-04-01 Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT06554639

    A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011)

    Not yet reported Merck Sharp & Dohme LLC 12 participants Est. completion 2024-08-29 1 site Stand-alone
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT06635720

    REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)

    Not yet reported The Hospital for Sick Children 50 participants Est. completion 2027-02-28 1 site Stand-alone
    Other conditions: Nephrotic Syndrome in Children, Nephrotic Syndrome, Minimal Change, Nephrotic Syndrome, Nephrotic Syndrome，Idiopathic
    View official trial listing →
  • Enrolling by invitation NCT NCT06635863

    Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat

    Not yet reported Roderick Tung 40 participants Est. completion 2027-10 1 site Stand-alone
    Other conditions: Ventricular Arrythmia, Non-ischemic Cardiomyopathy, Arrhythmogenic Inflammatory Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT06641440

    Treatment With Prednisone of Women With RPL or RIF Positive to Antithyroid Antibodies and Embryotoxicity Test

    Not yet reported Centre for Endocrinology and Reproductive Medicine, Italy 42 participants Est. completion 2024-10-10 2 sites Stand-alone
    Other conditions: Recurrent Pregnancy Loss, Not Pregnant, Recurrent Implantation Failure
    View official trial listing →
  • Not yet recruiting NCT NCT06643689

    Tranilast Vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial Neoplasms

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 394 participants Est. completion 2028-12-31 3 sites
    Other conditions: Esophageal Stricture, Esophageal Neoplasms
    View official trial listing →
  • Not yet recruiting NCT NCT06652152

    Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor Lymphoma

    Ruijin Hospital 400 participants Est. completion 2025-12-30
    Other conditions: Diffuse Large B Cell Lymphoma (DLBCL), Double Expressor Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT06701344

    Go-CHOP in de Novo Intestinal T-cell Lymphoma Patients

    Not yet reported Ruijin Hospital 7 participants Est. completion 2027-12-04 Stand-alone
    Other conditions: Enteropathy Associated T Cell Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT06723548

    Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

    Not yet reported First Affiliated Hospital of Wenzhou Medical University 30 participants Est. completion 2026-12 Stand-alone
    Other conditions: Myasthenia Gravis, Autoimmune Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT06789315

    Randomized Controlled Trial of Mycophenolate Mofetil Versus Steroid Therapy in Alcoholic Hepatitis

    Not yet reported Institute of Liver and Biliary Sciences, India 60 participants Est. completion 2026-01-31 1 site
    Other conditions: Alcoholic Hepatitis
    View official trial listing →
  • Not yet recruiting NCT NCT06833814

    DOSE Trial: Optimal Dose of Oral Corticosteroids to Treat Asthma Exacerbations

    Not yet reported Andréanne Côté 36 participants Est. completion 2025-12-31 Stand-alone
    Other conditions: Asthma Exacerbations
    View official trial listing →
  • Not yet recruiting NCT NCT06890832

    A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer

    Not yet reported Jina Pharmaceuticals Inc. 75 participants Est. completion 2027-06 Stand-alone
    Other conditions: Metastatic Castration-resistant Prostate Cancer, MCRPC
    View official trial listing →
  • Not yet recruiting NCT NCT06901999

    Methotrexate or Thiotepa Combined With R-CHOP and Orelabrutinib in CNSL Patients

    Not yet reported Ruijin Hospital 23 participants Est. completion 2028-11 Stand-alone
    Other conditions: CNS Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT06981845

    Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis

    Not yet reported China National Center for Cardiovascular Diseases 52 participants Est. completion 2028-06-01 Stand-alone
    Cardiovascular disease Other conditions: In-stent Restenosis Lesion
    View official trial listing →
  • Not yet recruiting NCT NCT07116811

    Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients

    Not yet reported Beijing Tiantan Hospital 364 participants Est. completion 2027-09-30 1 site Stand-alone
    Other conditions: Vestibular Schwannoma, Facial Nerve Paralysis
    View official trial listing →
  • Not yet recruiting NCT NCT07132398

    Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD

    Not yet reported Tianjin Medical University General Hospital 170 participants Est. completion 2028-08-31
    Other conditions: Neuromyelitis Optica (NMO), Neuromyelitis Optica Spectrum Disorders (NMOSD)
    View official trial listing →
  • Completed NCT NCT07380152

    Corticosteroid Therapy in Pulmonary Sequelae of Covid-19

    Not yet reported University of Sao Paulo 100 participants Est. completion 2022-12-12 1 site
    Other conditions: COVID-19 Pulmonary Complications
    View official trial listing →
  • Not yet recruiting NCT NCT07440238

    Evaluation of the Efficacy of Corticosteroids in Septic Arthritis in Adults

    Not yet reported Assistance Publique - Hôpitaux de Paris 200 participants Est. completion 2026-09 1 site Stand-alone
    Other conditions: Septic Arthritis
    View official trial listing →
  • Not yet recruiting NCT NCT07508514

    Early Temporal Dynamics of Optic Nerve Sheath Diameter After Therapy in GCA

    Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 60 participants Est. completion 2028-05-01 1 site
    Other conditions: Giant Cell Arteritis, Temporal Arteritis, Optic Nerve Diseases, Diagnosis
    View official trial listing →
  • Not yet recruiting NCT NCT07609446

    Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma

    The First Affiliated Hospital of Soochow University 30 participants Est. completion 2027-12-31 1 site
    Other conditions: Indolent Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Mantle Cell Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT07638787

    Pola-R-CHP Plus Sonrotoclax in Untreated BCL2-High/Double-Hit LBCL

    Not yet reported, Not yet reported Ruijin Hospital 40 participants Est. completion 2029-04-30 1 site Stand-alone
    Other conditions: Large B-cell Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT07650240

    Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial

    Not yet reported Mayo Clinic 202 participants Est. completion 2030-12-30 1 site Stand-alone
    Other conditions: Recurrent Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8, Castration-Sensitive Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer (mHSPC), Prostate Cancer, Prostate Adenocarcinoma, Adenocarcinoma of the Prostate, Localized Prostate Carcinoma, Metastatic Prostate Cancer, Metastatic Prostate Adenocarcinoma, Advanced Prostate Cancer, Advanced Prostate Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07663422

    Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy

    Not yet reported Fox Chase Cancer Center 31 participants Est. completion 2028-09-30 Stand-alone
    Other conditions: Immune-mediated Hepatitis, Immune-related Adverse Event
    View official trial listing →
  • Not yet recruiting NCT NCT07677813

    Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma

    Not yet reported Ou Bai, MD/PHD 66 participants Est. completion 2031-12-31 1 site Stand-alone
    Other conditions: DLBCL - Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT07730151

    Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer.

    Not yet reported RenJi Hospital 200 participants Est. completion 2031-12-31 Stand-alone
    Other conditions: Prostate Cancer, Prostate, Prostate Cancer Patients
    View official trial listing →
  • Not yet recruiting NCT NCT07730580

    Study of XNW5004 Tablets in Advanced Prostate Cancer

    Not yet reported Evopoint Biosciences Inc. 242 participants Est. completion 2028-12-31 Stand-alone
    Other conditions: Advanced Prostate Cancer
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Prednisone, Prednisone delayed release

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.